Could a simple pill let moms-to-be start labor at home?
NCT ID NCT05177510
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tests whether the drug mifepristone can safely and effectively start labor in pregnant women at home, reducing the need for hospital admission. About 400 women with a full-term, single baby and an unripe cervix will take the pill and be monitored. The goal is to see if more women go into labor within two days, improving comfort and lowering healthcare costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR, INDUCED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chelsea and Westminster Hospital
RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.